1h Free Analyst Time
The global coronary stent market is likely to reach more than $11 billion by 2024, growing at a CAGR of around 7% during 2018–2024.Speak directly to the analyst to clarify any post sales queries you may have.
The emergence of bioresorbable vascular scaffolds, the high growth potential of third generation DESs with low strut thickness, technological advancements and innovations, and new product approvals and launches are major factors, which are expected to drive the market in coming years.
The growing prevalence of cardiovascular diseases (CVD), especially vascular diseases, has been a major growth driver for the coronary stent market. Over the years, coronary stents have witnessed several technological enhancements, particularly design innovations. Stent manufacturers are focusing primarily on R&D activities and commercialization of innovative drug-eluting stent (DES) systems due to the high prevalence of coronary artery diseases.
New product approvals are contributing majorly toward the growth of the market and are likely to have a significant impact on the adoption of coronary stents in the coming years. Abbott, B. Braun Melsungen, Boston Scientific, Biosensors International GroupMedtronic, BIOTRONIK, Microport Scientific, and Terumo have launched a diverse range of drug-eluting stents in recent years, which are expected to augur well for the growth of the coronary stent market.
The market research report on the coronary stent market covers market sizing and forecast, market share, industry trends, growth drivers, and vendor analysis. The market study includes insights on segmentation by product (drug-eluting stents, bare metal stents, and bioresorbable stents), design (permanent, fully degradable), end-users (hospitals, specialty cardiology centers, ambulatory surgical centers), and geography (North America, Europe, APAC, Latin America, and MEA).
Coronary Stent Market: Segmentation
The market research report includes a detailed segmentation of the market by product, design, end-users, and geography. Bare metal stents are growing at a steady rate. High CAD occurrences, technological advancements, and a steady increase in demand in emerging economies are factors responsible for growth bare metal stents. Further, the demand for bare metal stents is likely to grow primarily from price-sensitive markets such as developing and low-income countries, where the uptake of PCI procedures has steadily increased over the past few years.
Bioresorbable stents are growing at a faster pace and are likely to witness rapid growth during the forecast period. With the availability of a few commercial and promising investigational devices, bioresorbable stents are likely to offer tremendous growth opportunities for vendors in coming years.
The permanent coronary stents segment is growing significantly and captured more than half of the market in 2018. Permanent heart stents are non-degradable devices made up from metal alloys such as stainless steel, cobalt chromium, and platinum chromium. They are gaining prominence in the market due to their safety and efficacy.
Fully degradable heart stents are growing at a stable rate. The rise in CVDs, especially vascular diseases, has become a major growth driver for innovative fully degradable types. Further, the heart stent manufacturers are focusing on R&D activities and commercialization of innovative products such as BRSs.Several emerging and major players are actively engaged in the development and commercialization of BRSs due to their huge market potential. For instance, Abbott is developing Absorb, second-generation BRS, and is actively conducting clinical trials to gain regulatory approvals.
Hospitals are the largest end-users of coronary stents. The growing aging population, changing lifestyle patterns, and the increasing prevalence of CVDs are fueling market growth. Further, a significant number of patients prefer to undergo surgeries in hospitals due to better reimbursement policies. The availability of reimbursement in hospitals is a major driver for the high volume of PCI procedures in the healthcare sector.The demand for highly advanced and innovative PCI procedures like robot-assisted techniques are being performed to implant a diverse array of drug eluting, bare metal, and bioabsorbable stents.
Market Segmentation by Product
- Drug-eluting stents
- Bare metal stents
- Bioresorbable stents
Market Segmentation by Design
- Permanent coronary stents
- Fully degradable coronary stents
Market Segmentation by End-users
- Hospitals
- Specialty cardiology centers
- Ambulatory surgical centers
Coronary Stent Market: Geography
North America captured half of the global coronary stent market in 2018. The presence of a large pool of patient population with CAD requiring coronary stents, a high acceptance of advanced and innovative heart stents, and high awareness toward stent-based PCI procedures have collectively supported North America’s dominance in the market.
Germany, the UK, France, Italy, and Spain are the major revenue contributors in the coronary stent market in Europe. The presence of highly sophisticated healthcare infrastructure, high awareness regarding advantages of PCI procedures, and increased R&D investments on innovative coronary stents are major driver driving the Europe coronary stent market.
Market Segmentation by Geography:
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- APAC
- China
- India
- Japan
- Latin America
- Mexico
- Brazil
- MEA
- Turkey
- Saudi Arabia
Key Vendor Analysis
The coronary stent market is highly dynamic due to the presence of several global, regional, and local players offering a broad range of stents. Vendors, especially global players, are increasingly focusing on pursuing inorganic growth strategies such as acquisitions and investments in startup and emerging companies to expand their presence, enhance product portfolio, and improve expertise in the market. Leading players are focusing on implementing strategies such as product approvals, expanded indication approvals, conducting clinical trials, marketing, and promotional activities, acquisitions, increase R&D investment, and strengthen their distribution networks to enhance their market share and presence in the coronary stent market.
Prominent Vendors
- Abbott
- Boston Scientific
- Medtronic
- BIOTRONIK
- Terumo
- Braun Melsungen
- Biosensors International Group
Other Prominent Vendors
- Arterial Remodeling Technologies
- Alvimedica
- Balton
- Cardionovum
- CeloNovaBioSciences
- Comed
- Cordis
- Elixir Medical
- Endocor
- Eucatech
- Eurocor Tech
- Hexacath
- InSitu Technologies
- Innovative Healthcare Technologies
- Lepu Medical Technology (Beijing)
- Medinol
- Meril Life Sciences
- Micell Technologies
- MicroPort Scientific
- Minvasys
- OrbuSneich Medical
- Q3 Medical Devices
- REVA Medical
- Rontis
- S3V Vascular Technologies
- Sahajanand Medical Technologies
- SCITECH
- Stentys
- Svelte Medical
- Translumina Therapeutics
- USM Healthcare
- Vascular Concepts
- Wellinq
Key Market Insights
- Offers market sizing and growth prospects of functional coronary stent market for the forecast period 2019–2024
- Provides comprehensive insights on the latest industry trends, market forecast, and growth drivers in the coronary stent market
- Includes a detailed analysis of market growth drivers, challenges, and investment opportunities
- Delivers a complete overview of market segments and the regional outlook of coronary stent market
- Offers an exhaustive summary of the vendor landscape, competitive analysis, and key market strategies to gain a competitive advantage in the coronary stent market
Table of Contents
1 Research Methodology2 Research Objectives3 Research Process6 Market at a Glance
4 Scope & Coverage
5 Report Assumptions & Caveats
7 Introduction
8 Market Dynamics
9 Global Coronary Stents Market
10 By Product Type
11 By Design Type
12 By End-Users
13 By Geography
14 North America
15 Europe
16 APAC
17 Latin America
18 Middle-East and Africa
19 Competitive Landscape
20. Key Company Profiles
21. Other Prominent Vendors
22. Report Summary
23. Appendix
List of Exhibits
List of Tables
Companies Mentioned
- Abbott
- Boston Scientific
- Medtronic
- BIOTRONIK
- Terumo
- Braun Melsungen
- Biosensors International Group
- Arterial Remodeling Technologies
- Alvimedica
- Balton
- Cardionovum
- CelonovaBioSciences
- Comed
- Cordis
- Elixir Medical
- Endocor
- Eucatech
- Eurocor Tech
- Hexacath
- InSitu Technologies
- Innovative Healthcare Technologies
- Lepu Medical Technology (Beijing)
- Medinol
- Meril Life Sciences
- Micell Technologies
- MicroPort Scientific
- Minvasys
- OrbuSneich Medical
- Q3 Medical Devices
- REVA Medical
- Rontis
- S3V Vascular Technologies
- Sahajanand Medical Technologies
- Scitech
- Stentys
- Svelte Medical
- Translumina Therapeutics
- USM Healthcare
- Vascular Concepts
- Wellinq.
Methodology
Our research comprises a mix of primary and secondary research. The secondary research sources that are typically referred to include, but are not limited to, company websites, annual reports, financial reports, company pipeline charts, broker reports, investor presentations and SEC filings, journals and conferences, internal proprietary databases, news articles, press releases, and webcasts specific to the companies operating in any given market.
Primary research involves email interactions with the industry participants across major geographies. The participants who typically take part in such a process include, but are not limited to, CEOs, VPs, business development managers, market intelligence managers, and national sales managers. We primarily rely on internal research work and internal databases that we have populated over the years. We cross-verify our secondary research findings with the primary respondents participating in the study.
LOADING...
